HK1045109A1 - 列出後葉加壓素拮抗物的公式及步驟 - Google Patents

列出後葉加壓素拮抗物的公式及步驟

Info

Publication number
HK1045109A1
HK1045109A1 HK02106544.6A HK02106544A HK1045109A1 HK 1045109 A1 HK1045109 A1 HK 1045109A1 HK 02106544 A HK02106544 A HK 02106544A HK 1045109 A1 HK1045109 A1 HK 1045109A1
Authority
HK
Hong Kong
Prior art keywords
vasopressin antagonist
antagonist formulation
formulation
vasopressin
antagonist
Prior art date
Application number
HK02106544.6A
Other languages
English (en)
Chinese (zh)
Inventor
Kyuwung Yoon Joseph
William Saunders Richard
Bakir Fawzi Mahdi
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of HK1045109A1 publication Critical patent/HK1045109A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK02106544.6A 1999-09-27 2002-09-05 列出後葉加壓素拮抗物的公式及步驟 HK1045109A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40577299A 1999-09-27 1999-09-27
PCT/US2000/026369 WO2001022945A1 (en) 1999-09-27 2000-09-26 Vasopressin antagonist formulation and process

Publications (1)

Publication Number Publication Date
HK1045109A1 true HK1045109A1 (zh) 2002-11-15

Family

ID=23605168

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02106544.6A HK1045109A1 (zh) 1999-09-27 2002-09-05 列出後葉加壓素拮抗物的公式及步驟

Country Status (18)

Country Link
EP (1) EP1216033A1 (ja)
JP (1) JP2003510269A (ja)
KR (1) KR20020039354A (ja)
CN (1) CN1391466A (ja)
AR (1) AR025780A1 (ja)
AU (1) AU7615000A (ja)
BR (1) BR0014351A (ja)
CA (1) CA2388474A1 (ja)
CZ (1) CZ20021083A3 (ja)
EA (1) EA200200414A1 (ja)
HK (1) HK1045109A1 (ja)
HU (1) HUP0202972A3 (ja)
IL (1) IL148541A0 (ja)
MX (1) MXPA02003189A (ja)
NO (1) NO20021475L (ja)
PL (1) PL354282A1 (ja)
WO (1) WO2001022945A1 (ja)
ZA (1) ZA200203312B (ja)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030105144A1 (en) * 2001-04-17 2003-06-05 Ping Gao Stabilized oral pharmaceutical composition
AU2003211267A1 (en) * 2002-02-27 2003-09-09 Shionogi And Co., Ltd. Solid preparations with improved absorbability of hardly water-soluble drug
JP5873375B2 (ja) * 2012-04-03 2016-03-01 中日本カプセル 株式会社 ソフトカプセル及びソフトカプセルの製造方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5516774A (en) * 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
EP1049459B1 (en) * 1998-01-20 2009-04-22 Applied Analytical Industries, Inc. Oral liquid compositions

Also Published As

Publication number Publication date
MXPA02003189A (es) 2002-09-30
KR20020039354A (ko) 2002-05-25
IL148541A0 (en) 2002-09-12
EP1216033A1 (en) 2002-06-26
CZ20021083A3 (cs) 2002-06-12
HUP0202972A2 (hu) 2002-12-28
AR025780A1 (es) 2002-12-11
HUP0202972A3 (en) 2003-07-28
ZA200203312B (en) 2003-12-31
WO2001022945A1 (en) 2001-04-05
CA2388474A1 (en) 2001-04-05
CN1391466A (zh) 2003-01-15
EA200200414A1 (ru) 2002-12-26
NO20021475D0 (no) 2002-03-25
NO20021475L (no) 2002-04-16
BR0014351A (pt) 2002-06-11
PL354282A1 (en) 2003-12-29
AU7615000A (en) 2001-04-30
JP2003510269A (ja) 2003-03-18

Similar Documents

Publication Publication Date Title
HUP0201489A3 (en) New formulation
HK1044329A1 (en) Concrete formulation
IL148489A0 (en) Quinazoline compounds and pharmaceutical compositions containing them
HK1040995A1 (zh) 二氧喹啉化合物及其醫藥用途
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
IL146230A0 (en) 3α-HYDROXY-3β-METHOXYMETHYL-SUBSTITUTED STEROIDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
EG24226A (en) Formulation
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB9909898D0 (en) Cleaning compositions and tablets
GB9905898D0 (en) Controlled-dose formulation
GB9902304D0 (en) Formulation
AU7615200A (en) Vasopressin agonist formulation and process
IL148541A0 (en) Vasopressin antagonist formulation and process
GB9909154D0 (en) Pharmaceutical formulation
GB9927614D0 (en) Sterliant formulation
GB9926251D0 (en) Pharmaceutical formulation
AU1623801A (en) Opioid metallopeptide compositions and methods
GB9902236D0 (en) Formulation
GB9908776D0 (en) Formulation
GB9902089D0 (en) Formulation
GB9917952D0 (en) Formulation
GB9915584D0 (en) Formulation
GB9923538D0 (en) Formulation
AU7615100A (en) Vasopressin antagonist and diuretic combination
IL132705A0 (en) Compounds and pharmaceutical compositions comprising same